Works by Schwartz, Gary K

Results: 70

A Phase I Dose-Escalation Study of LY3405105, a Covalent Inhibitor of Cyclin-Dependent Kinase 7, Administered to Patients With Advanced Solid Tumors.

Published in:

Oncologist, 2024, v. 29, n. 1, p. e131, doi. 10.1093/oncolo/oyad215

By:

Garralda, Elena;
Schram, Alison M;
Bedard, Philippe L;
Schwartz, Gary K;
Yuen, Eunice;
McNeely, Samuel C;
Ribeiro, Silvia;
Cunningham, Jason;
Wang, Yi;
Urunuela, Arantxa;
Xu, Xiaojian;
LoRusso, Patricia

Publication type:

Article

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

Published in:

Oncologist, 2019, v. 24, n. 6, p. 857, doi. 10.1634/theoncologist.2018-0160

By:

D'Adamo, David R.;
Dickson, Mark A.;
Keohan, Mary L.;
Carvajal, Richard D.;
Hensley, Martee L.;
Hirst, Catherine M.;
Ezeoke, Marietta O.;
Ahn, Linda;
Qin, Li‐Xuan;
Antonescu, Cristina R.;
Lefkowitz, Robert A.;
Maki, Robert G.;
Schwartz, Gary K.;
Tap, William D.

Publication type:

Article

A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas.

Published in:

Oncologist, 2015, v. 20, n. 11, p. 1245, doi. 10.1634/theoncologist.2015-0245

By:

Munhoz, Rodrigo R.;
D'Angelo, Sandra P.;
Gounder, Mrinal M.;
Keohan, Mary L.;
Chi, Ping;
Carvajal, Richard D.;
Singer, Samuel;
Crago, Aimee M.;
Landa, Jonathan;
Healey, John H.;
Qin, Li‐Xuan;
Hameed, Meera;
Ezeoke, Marietta O.;
Singh, Arun S.;
Agulnik, Mark;
Chmielowski, Bartosz;
Luke, Jason J.;
Van Tine, Brian A.;
Schwartz, Gary K.;
Tap, William D.

Publication type:

Article

Genetic analysis of the 'uveal melanoma' C918 cell line reveals atypical BRAF and common KRAS mutations and single tandem repeat profile identical to the cutaneous melanoma C8161 cell line.

Published in:

Pigment Cell & Melanoma Research, 2015, v. 28, n. 3, p. 357, doi. 10.1111/pcmr.12345

By:

Yu, Xiaoxing;
Ambrosini, Grazia;
Roszik, Jason;
Eterovic, Agda Karina;
Stempke ‐ Hale, Katherine;
Seftor, Elisabeth A.;
Chattopadhyay, Chandrani;
Grimm, Elizabeth;
Carvajal, Richard D.;
Hendrix, Mary J. C.;
Hodi, F. Stephen;
Schwartz, Gary K.;
Woodman, Scott E.

Publication type:

Article

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.

Published in:

Sarcoma, 2015, v. 2015, p. 1, doi. 10.1155/2015/532478

By:

Dickson, Mark A.;
D’Adamo, David R.;
Keohan, Mary L.;
D’Angelo, Sandra P.;
Carvajal, Richard D.;
Gounder, Mrinal M.;
Maki, Robert G.;
Qin, Li-Xuan;
Lefkowitz, Robert A.;
McKennon, Olivia R.;
Hirst, Catherine M.;
Schwartz, Gary K.;
Tap, William D.

Publication type:

Article

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.

Published in:

2013

By:

Maki, Robert G.;
Jungbluth, Achim A.;
Gnjatic, Sacha;
Schwartz, Gary K.;
D'Adamo, David R.;
Keohan, Mary Louise;
Wagner, Michael J.;
Scheu, Kelly;
Chiu, Rita;
Ritter, Erika;
Kachel, Jennifer;
Lowy, Israel;
Old, Lloyd J.;
Ritter, Gerd

Publication type:

Journal Article

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma.

Published in:

Sarcoma, 2013, p. 1, doi. 10.1155/2013/168145

By:

Maki, Robert G.;
Jungbluth, Achim A.;
Gnjatic, Sacha;
Schwartz, Gary K.;
D'Adamo, David R.;
Keohan, Mary Louise;
Wagner, Michael J.;
Scheu, Kelly;
Chiu, Rita;
Ritter, Erika;
Kachel, Jennifer;
Lowy, Israel;
Old, Lloyd J.;
Ritter, Gerd

Publication type:

Article

Ifosfamide May Be Safely Used in Patients with End Stage Renal Disease on Hemodialysis.

Published in:

2009

By:

Latcha, Sheron;
Maki, Robert G.;
Schwartz, Gary K.;
Flombaum, Carlos D.

Publication type:

Case Study

Inhibition of polo like kinase 1 in sarcomas induces apoptosis that is dependent on Mcl-1 suppression.

Published in:

Cell Cycle, 2015, v. 14, n. 19, p. 3101, doi. 10.1080/15384101.2015.1078033

By:

Nair, Jayasree S;
Schwartz, Gary K

Publication type:

Article

Early treatment-related neutropenia predicts response to palbociclib.

Published in:

2020

By:

McAndrew, Nicholas P.;
Dickson, Mark A.;
Clark, Amy S.;
Troxel, Andrea B.;
O'Hara, Mark H.;
Colameco, Christopher;
Gallager, Maryann;
Gramlich, Kristi;
Zafman, Kelly;
Vaughn, David;
Schwartz, Gary K.;
O'Dwyer, Peter J.;
DeMichele, Angela

Publication type:

journal article

Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.

Published in:

2018

By:

Yokota, Tomoya;
Bendell, Johanna;
LoRusso, Patricia;
Tsushima, Takahiro;
Desai, Ved;
Kenmotsu, Hirotsugu;
Watanabe, Junichiro;
Ono, Akira;
Murugesan, Bhavani;
Silva, Joseph;
Naito, Tateaki;
Greenberg, Jonathan;
Kumar, Prasanna;
Wang, Yibin;
Jikoh, Takahiro;
Shiga, Ryota;
Hyman, David M.;
Ho, Alan Loh;
Spriggs, David R.;
Schwartz, Gary K.

Publication type:

journal article

Preclinical and first-in-human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with insulin-like growth factor receptor-1/insulin receptor selectivity.

Published in:

Cancer Science, 2016, v. 107, n. 4, p. 499, doi. 10.1111/cas.12906

By:

Schwartz, Gary K.;
Dickson, Mark A.;
LoRusso, Patricia M.;
Sausville, Edward A.;
Maekawa, Yoshimi;
Watanabe, Yasuo;
Kashima, Naomi;
Nakashima, Daisuke;
Akinaga, Shiro

Publication type:

Article

Preclinical study of treatment response in HCT-116 cells and xenografts with <sup>1</sup>H-decoupled <sup>31</sup>P MRS.

Published in:

NMR in Biomedicine, 2011, v. 24, n. 9, p. 1159, doi. 10.1002/nbm.1674

By:

Darpolor, Moses M.;
Kennealey, Peter T.;
Le, H. Carl;
Zakian, Kristen L.;
Ackerstaff, Ellen;
Rizwan, Asif;
Chen, Jin-Hong;
Sambol, Elliot B.;
Schwartz, Gary K.;
Singer, Samuel;
Koutcher, Jason A.

Publication type:

Article

Ipilimumab for Patients With Advanced Mucosal Melanoma.

Published in:

Oncologist, 2013, v. 18, n. 6, p. 726, doi. 10.1634/theoncologist.2012-0464

By:

Postow, Michael A.;
Luke, Jason J.;
Bluth, Mark J.;
Ramaiya, Nikhil;
Panageas, Katherine S.;
Lawrence, Donald P.;
Ibrahim, Nageatte;
Flaherty, Keith T.;
Sullivan, Ryan J.;
Ott, Patrick A.;
Callahan, Margaret K.;
Harding, James J.;
D'Angelo, Sandra P.;
Dickson, Mark A.;
Schwartz, Gary K.;
Chapman, Paul B.;
Gnjatic, Sacha;
Wolchok, Jedd D.;
Hodi, F. Stephen;
Carvajal, Richard D.

Publication type:

Article

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1

By:

Dickson, Mark A.;
Shah, Manish A.;
Rathkopf, Dana;
Tse, Archie;
Carvajal, Richard D.;
Nian Wu;
Lefkowitz, Robert A.;
Gonen, Mithat;
Cane, Lauren M.;
Dials, Heather J.;
Schwartz, Gary K.

Publication type:

Article

Preclinical pharmacokinetic/pharmacodynamic models to predict synergistic effects of co-administered anti-cancer agents.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 2, p. 245, doi. 10.1007/s00280-009-1153-z

By:

Goteti, Kosalaram;
Garner, C. Edwin;
Utley, Lucas;
Jing Dai;
Ashwell, Susan;
Moustakas, Demetri T.;
Gönen, Mithat;
Schwartz, Gary K.;
Kern, Steven E.;
Zabludoff, Sonya;
Brassil, Patrick J.

Publication type:

Article

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Published in:

2008

By:

Ku GY;
Ilson DH;
Schwartz LH;
Capanu M;
O'Reilly E;
Shah MA;
Kelsen DP;
Schwartz GK;
Ku, Geoffrey Y;
Ilson, David H;
Schwartz, Lawrence H;
Capanu, Marinela;
O'Reilly, Eileen;
Shah, Manish A;
Kelsen, David P;
Schwartz, Gary K

Publication type:

journal article

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 5, p. 875, doi. 10.1007/s00280-008-0677-y

By:

Ku, Geoffrey Y.;
Ilson, David H.;
Schwartz, Lawrence H.;
Capanu, Marinela;
O'Reilly, Eileen;
Shah, Manish A.;
Kelsen, David P.;
Schwartz, Gary K.

Publication type:

Article

Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.

Published in:

Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 5, p. 389, doi. 10.1007/s002800051007

By:

Hsueh, Chung-Tsen;
Chiu, Chang-Fang;
Kelsen, David P.;
Schwartz, Gary K.

Publication type:

Article

A phase 2 study of MK‐2206 in patients with incurable adenoid cystic carcinoma (Alliance A091104).

Published in:

Cancer (0008543X), 2024, v. 130, n. 5, p. 702, doi. 10.1002/cncr.35103

By:

Ho, Alan L.;
Foster, Nathan R.;
Deraje Vasudeva, Shyamprasad;
Katabi, Nora;
Antonescu, Cristina R.;
Frenette, Gary P.;
Pfister, David G.;
Erlichman, Charles;
Schwartz, Gary K.

Publication type:

Article

Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.

Published in:

Cancer (0008543X), 2024, v. 130, n. 5, p. 750, doi. 10.1002/cncr.35078

By:

Rosenberg, Shoshana M.;
McCue, Shaylene;
He, Jun;
Lafky, Jacqueline M.;
Carey, Lisa A.;
Galanis, Evanthia;
Leonard, John P.;
Meyerhardt, Jeffrey;
Ng, Kimmie;
Schwartz, Gary K.;
Stock, Wendy;
Paskett, Electra D.;
Partridge, Ann H.;
George, Suzanne

Publication type:

Article

Readability of Cancer Clinical Trials Websites.

Published in:

2020

By:

Hillyer, Grace Clarke;
Beauchemin, Melissa;
Garcia, Philip;
Kelsen, Moshe;
Brogan, Frances L.;
Schwartz, Gary K.;
Basch, Corey H.

Publication type:

journal article

Readability of Cancer Clinical Trials Websites.

Published in:

Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 1, p. 1, doi. 10.1177/1073274819901125

By:

Hillyer, Grace Clarke;
Beauchemin, Melissa;
Garcia, Philip;
Kelsen, Moshe;
Brogan, Frances L.;
Schwartz, Gary K.;
Basch, Corey H.

Publication type:

Article

Readability of Cancer Clinical Trials Websites.

Published in:

Cancer Control: Journal of the Moffitt Cancer Center, 2020, v. 27, n. 1, p. 1, doi. 10.1177/1073274819901125

By:

Hillyer, Grace Clarke;
Beauchemin, Melissa;
Garcia, Philip;
Kelsen, Moshe;
Brogan, Frances L.;
Schwartz, Gary K.;
Basch, Corey H.

Publication type:

Article

PMA-induced reduction in invasiveness is associated with hyperphosphorylation of MARCKS and talin in invasive bladder cancer cells.

Published in:

International Journal of Cancer, 1998, v. 75, n. 5, p. 774, doi. 10.1002/(SICI)1097-0215(19980302)75:5<774::AID-IJC18>3.0.CO;2-6

By:

Yokoyama, Yasuhiro;
Ito, Tetsushi;
Hanson, Veneta;
Schwartz, Gary K.;
Aderem, Alan A.;
Holland, James F.;
Tamaya, Teruhiko;
Ohnuma, Takao

Publication type:

Article

The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Published in:

International Journal of Cancer, 1995, v. 64, n. 1, p. 37, doi. 10.1002/ijc.2910640109

By:

Nabeya, Yoshihiro;
Loganzo, Frank;
Maslak, Peter;
Lai, Lawrence;
De Oliveira, Alice R.;
Schwartz, Gary K.;
Blundell, Maude L.;
Altorki, Nasser K.;
Kelsen, David P.;
Albino, Anthony P.

Publication type:

Article

Bryostatin-1: A Novel PKC Inhibitor in Clinical Development #.

Published in:

Cancer Investigation, 2003, v. 21, n. 6, p. 924, doi. 10.1081/CNV-120025095

By:

Kortmansky, Jeremy;
Schwartz, Gary K.

Publication type:

Article

High frequency of simultaneous loss of p16 and p16β gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.

Published in:

Oncogene, 1997, v. 15, n. 12, p. 1481, doi. 10.1038/sj.onc.1201295

By:

Hayashi, Kazuhiko;
Metzger, Ralf;
Salonga, Dennis;
Danenberg, Kathleen;
Leichman, Lawrence P;
Fink, Ulrich;
Sendler, Andreas;
Kelsen, David;
Schwartz, Gary K;
Groshen, Susan;
Lenz, Heinz-Josef;
Danenberg, Peter V

Publication type:

Article

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.

Published in:

Cancers, 2020, v. 12, n. 7, p. 1768, doi. 10.3390/cancers12071768

By:

Amin, Hesham M.;
Morani, Ajaykumar C.;
Daw, Najat C.;
Lamhamedi-Cherradi, Salah-Eddine;
Subbiah, Vivek;
Menegaz, Brian A.;
Vishwamitra, Deeksha;
Eskandari, Ghazaleh;
George, Bhawana;
Benjamin, Robert S.;
Patel, Shreyaskumar;
Song, Juhee;
Lazar, Alexander J.;
Wang, Wei-Lien;
Kurzrock, Razelle;
Pappo, Alberto;
Anderson, Peter M.;
Schwartz, Gary K.;
Araujo, Dejka;
Cuglievan, Branko

Publication type:

Article

KIT as a Therapeutic Target in Metastatic Melanoma.

Published in:

JAMA: Journal of the American Medical Association, 2011, v. 305, n. 22, p. 2327, doi. 10.1001/jama.2011.746

By:

Carvajal, Richard D.;
Antonescu, Cristins R.;
Wolchok, Jedd D.;
Chapman, Paul B.;
Roman, Ruth-Ann;
Teitcher, Jerrold;
Panageas, Katherine S.;
Busam, Klaus J.;
Chmielowski, Bartosz;
Lutzky, Jose;
Pavlick, Anna C.;
Fusco, Anne;
Cane, Lauren;
Takebe, Naoko;
Vemula, Swapna;
Bouvier, Nancy;
Bastian, Boris C.;
Schwartz, Gary K.

Publication type:

Article

The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent.

Published in:

Cell Cycle, 2012, v. 11, n. 4, p. 807, doi. 10.4161/cc.11.4.19323

By:

Nair, Jayasree S.;
Ho, Alan L.;
Schwartz, Gary K.

Publication type:

Article

CDK Inhibitors--Cell Cycle Arrest Versus Apoptosis.

Published in:

Cell Cycle, 2002, v. 1, n. 2, p. 122, doi. 10.4161/cc.1.2.112

By:

Schwartz, Gary K.

Publication type:

Article

Chemotherapy and P-glycoprotein expression in chondrosarcoma.

Published in:

Journal of Orthopaedic Research, 1998, v. 16, n. 5, p. 585, doi. 10.1002/jor.1100160510

By:

Terek, Richard M.;
Schwartz, Gary K.;
Devaney, Kenneth;
Glantz, Lisa;
Mak, Solida;
Healey, John H.;
Albino, Anthony P.

Publication type:

Article

Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.

Published in:

Investigational New Drugs, 2024, v. 42, n. 1, p. 127, doi. 10.1007/s10637-024-01420-8

By:

Emiloju, Oluwadunni E.;
Yin, Jun;
Koubek, Emily;
Reid, Joel M.;
Borad, Mitesh J.;
Lou, Yanyan;
Seetharam, Mahesh;
Edelman, Martin J.;
Sausville, Edward A.;
Jiang, Yixing;
Kaseb, Ahmed O.;
Posey, James A.;
Davis, Sarah L.;
Gores, Gregory J.;
Roberts, Lewis R.;
Takebe, Naoko;
Schwartz, Gary K.;
Hendrickson, Andrea E. Wahner;
Kaufmann, Scott H.;
Adjei, Alex A.

Publication type:

Article

Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.

Published in:

1993

By:

Schwartz, Gary. K.;
Jiang, Jack;
Kelsen, David;
Albino, Anthony P.;
Schwartz, G K;
Jiang, J;
Kelsen, D;
Albino, A P

Publication type:

journal article

Inhibition of Invasion of Invasive Human Bladder Carcinoma Cells by Protein Kinase C Inhibitor Staurosporine.

Published in:

JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 22, p. 1753

By:

Schwartz, Gary K.;
Redwood, S. Mark;
Ohnuma, Takao;
Holland, James F.;
Droller, Michael J.;
Liu, Brian C.–S.

Publication type:

Article

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975643

By:

Khan, Shaheer;
Patel, Sapna P.;
Shoushtari, Alexander N.;
Ambrosini, Grazia;
Cremers, Serge;
Shing Lee;
Franks, Lauren;
Singh-Kandah, Shahnaz;
Hernandez, Susana;
Sender, Naomi;
Vuolo, Kristina;
Nesson, Alexandra;
Mundi, Prabhjot;
Izar, Benjamin;
Schwartz, Gary K.;
Carvajal, Richard D.

Publication type:

Article

Extrarenal perivascular epithelioid cell tumors (PEComas) respond to mTOR inhibition: Clinical and molecular correlates.

Published in:

International Journal of Cancer, 2013, v. 132, n. 7, p. 1711, doi. 10.1002/ijc.27800

By:

Dickson, Mark A.;
Schwartz, Gary K.;
Antonescu, Cristina R.;
Kwiatkowski, David J.;
Malinowska, Izabela A.

Publication type:

Article

TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma.

Published in:

Nature Communications, 2016, v. 7, n. 8, p. 12609, doi. 10.1038/ncomms12609

By:

Jung, Joonil;
Lee, Joon Sang;
Dickson, Mark A.;
Schwartz, Gary K.;
Le Cesne, Axel;
Varga, Andrea;
Bahleda, Rastilav;
Wagner, Andrew J.;
Choy, Edwin;
de Jonge, Maja J.;
Light, Madelyn;
Rowley, Steve;
Macé, Sandrine;
Watters, James

Publication type:

Article

Down-regulation of the tumor suppressor miR-34a contributes to head and neck cancer by up-regulating the MET oncogene and modulating tumor immune evasion.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01865-2

By:

Wu, Xun;
Cheng, Yi-Shing Lisa;
Matthen, Mathew;
Yoon, Angela;
Schwartz, Gary K.;
Bala, Shashi;
Taylor, Alison M.;
Momen-Heravi, Fatemeh

Publication type:

Article

Pharmacokinetics of dacarbazine and unesbulin and CYP1A2‐mediated drug interactions in patients with leiomyosarcoma.

Published in:

CTS: Clinical & Translational Science, 2024, v. 17, n. 2, p. 1, doi. 10.1111/cts.13709

By:

Gao, Lan;
Kaushik, Diksha;
Van Tine, Brian A.;
Ingham, Matthew A.;
Attia, Steven;
Meyer, Christian F.;
Schwartz, Gary K.;
Maliakal, Pius;
Baird, John D.;
Ma, Jiyuan;
Barrett, Rosemary;
D'Silva, Dhiren;
O'Keefe, Kylie;
Kong, Ronald

Publication type:

Article

Community education to enhance the more equitable use of precision medicine in Northern Manhattan.

Published in:

Journal of Genetic Counseling, 2020, v. 29, n. 2, p. 247, doi. 10.1002/jgc4.1244

By:

Hillyer, Grace C.;
Schmitt, Karen M.;
Reyes, Andria;
Cruz, Alejandro;
Lizardo, Maria;
Schwartz, Gary K.;
Terry, Mary Beth

Publication type:

Article

Clinical trial enrollment of adolescents and young adults with sarcoma.

Published in:

Cancer (0008543X), 2017, v. 123, n. 18, p. 3434, doi. 10.1002/cncr.30757

By:

Davis, Lara E.;
Janeway, Katherine A.;
Weiss, Aaron R.;
Chen, Yen-Lin E.;
Scharschmidt, Thomas J.;
Krailo, Mark;
Glade Bender, Julia L.;
Kopp, Lisa M.;
Patel, Shreyaskumar R.;
Schwartz, Gary K.;
Horvath, L. Elise;
Hawkins, Douglas S.;
Chuk, Meredith K.;
Reinke, Denise K.;
Gorlick, Richard G.;
Randall, R. Lor

Publication type:

Article

Patient-derived xenografts for individualized care in advanced sarcoma.

Published in:

Cancer (0008543X), 2014, v. 120, n. 13, p. 2006, doi. 10.1002/cncr.28696

By:

Stebbing, Justin;
Paz, Keren;
Schwartz, Gary K.;
Wexler, Leonard H.;
Maki, Robert;
Pollock, Raphael E.;
Morris, Ronnie;
Cohen, Richard;
Shankar, Arjun;
Blackman, Glen;
Harding, Victoria;
Vasquez, David;
Krell, Jonathan;
Ciznadija, Daniel;
Katz, Amanda;
Sidransky, David

Publication type:

Article

Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Published in:

2013

By:

Luke, Jason J;
Callahan, Margaret K;
Postow, Michael A;
Romano, Emanuela;
Ramaiya, Nikhil;
Bluth, Mark;
Giobbie-Hurder, Anita;
Lawrence, Donald P;
Ibrahim, Nageatte;
Ott, Patrick A;
Flaherty, Keith T;
Sullivan, Ryan J;
Harding, James J;
D'Angelo, Sandra;
Dickson, Mark;
Schwartz, Gary K;
Chapman, Paul B;
Wolchok, Jedd D;
Hodi, F Stephen;
Carvajal, Richard D

Publication type:

journal article

Clinical Activity of Ipilimumab for Metastatic Uveal Melanoma.

Published in:

Cancer (0008543X), 2013, v. 119, n. 20, p. 3687, doi. 10.1002/cncr.28282

By:

Luke, Jason J.;
Callahan, Margaret K.;
Postow, Michael A.;
Romano, Emanuela;
Ramaiya, Nikhil;
Bluth, Mark;
Giobbie‐Hurder, Anita;
Lawrence, Donald P.;
Ibrahim, Nageatte;
Ott, Patrick A.;
Flaherty, Keith T.;
Sullivan, Ryan J.;
Harding, James J.;
D'Angelo, Sandra;
Dickson, Mark;
Schwartz, Gary K.;
Chapman, Paul B.;
Wolchok, Jedd D.;
Hodi, F. Stephen;
Carvajal, Richard D.

Publication type:

Article

E-cigarette Use Among Young Adult Patients: The Opportunity to Intervene on Risky Lifestyle Behaviors to Reduce Cancer Risk.

Published in:

Journal of Community Health, 2022, v. 47, n. 1, p. 94, doi. 10.1007/s10900-021-01027-7

By:

Hillyer, Grace C.;
Nazareth, Meaghan;
Lima, Sarah;
Schmitt, Karen M.;
Reyes, Andria;
Fleck, Elaine;
Schwartz, Gary K.;
Terry, Mary Beth

Publication type:

Article

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study.

Published in:

Cancers, 2022, v. 14, n. 17, p. 4334, doi. 10.3390/cancers14174334

By:

Wagner, Michael J.;
Hennessy, Cassandra;
Beeghly, Alicia;
French, Benjamin;
Shah, Dimpy P.;
Croessmann, Sarah;
Vilar-Compte, Diana;
Ruiz-Garcia, Erika;
Ingham, Matthew;
Schwartz, Gary K.;
Painter, Corrie A.;
Chugh, Rashmi;
Fecher, Leslie;
Park, Cathleen;
Zamulko, Olga;
Trent, Jonathan C.;
Subbiah, Vivek;
Khaki, Ali Raza;
Tachiki, Lisa;
Nakasone, Elizabeth S.

Publication type:

Article

A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma.

Published in:

Cancers, 2021, v. 13, n. 21, p. 5504, doi. 10.3390/cancers13215504

By:

Shoushtari, Alexander N.;
Khan, Shaheer;
Komatsubara, Kimberly;
Feun, Lynn;
Acquavella, Nicolas;
Singh-Kandah, Shahnaz;
Negri, Tiffany;
Nesson, Alexandra;
Abbate, Kelly;
Cremers, Serge;
Musi, Elgilda;
Ambrosini, Grazia;
Lee, Shing;
Schwartz, Gary K.;
Carvajal, Richard D.

Publication type:

Article

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.

Published in:

2001

By:

O'Reilly, Eileen M.;
Stuart, Keith E.;
Sanz-Altamira, Pedro M.;
Schwartz, Gary K.;
Steger, Carolyn M.;
Raeburn, Lynn;
Kemeny, Nancy E.;
Kelsen, David P.;
Saltz, Leonard B.;
O'Reilly, E M;
Stuart, K E;
Sanz-Altamira, P M;
Schwartz, G K;
Steger, C M;
Raeburn, L;
Kemeny, N E;
Kelsen, D P;
Saltz, L B

Publication type:

journal article